Description
The recent union between our Raman analyzers equipped with Rxn-46 bioprocess probe technology and the BioPAT® Spectro platform by Sartorius offers the market an ideal interface to high throughput development through single-use commercial manufacturing. Our Raman bioprocessing probe technology has been adapted to fit Sartorius’s BioPAT® Spectro platform, utilizing the same probe design for Ambr® 15, Ambr® 250, & Biostat STR® bioreactors.
Benefits: Enables faster, easier, and more robust model building via integration with Ambr® 15 and Ambr® 250, Allows high throughput process development which supports QbD; Provides a more efficient transfer to Biostat STR® for single-use manufacturing; Offers a scale-independent interface from 15 ml in the laboratory to 2000 L in the production suite; Requires no probe cleaning, sterilization, or frequent maintenance due to non-contact sampling.